OCUL logo

Ocular Therapeutix (OCUL) Depreciation And Amortization

Annual D&A

$3.79 M
+$803.00 K+26.92%

December 31, 2024

Summary

Performance

1-Year Change

+26.92%

3-Year Change

+56.38%

5-Year Change

+49.64%

15-Year Change

+132.98%

OCUL Depreciation And Amortization Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Sector Rank

58.89%
OCUL annual depreciation & amortization is higher than 58.89% of companies in Healthcare sector

High & Low

All-time High

$3.79 M
OCUL annual depreciation & amortization is currently at an all-time high

3-Year Low

$2.11 M
OCUL annual depreciation & amortization is currently +79.52% above its 3-year low

Earnings dates

Last Annual Earnings Report Date

Dec 31, 2024
OCUL previous annual earnings announcement was published on Dec 31, 2024

Next Annual Earnings Report Date

N/A
OCUL next annual earnings announcement has not yet been scheduled

Related metrics

Annual Total Expenses

$235.50 M
OCUL annual total expenses is $235.50 million

Annual Operating Expenses

$229.88 M
OCUL annual total operating expenses is $229.88 million

Annual Cost Of Goods Sold

$5.63 M
OCUL annual cost of goods sold is $5.63 million

Annual Interest Expense

$13.58 M
OCUL annual interest expense is $13.58 million

Quarterly D&A

$951.00 K
-$8000.00-0.83%

December 31, 2024

Summary

Performance

3-Month Change

-0.83%

1-Year Change

-0.83%

3-Year Change

+66.84%

5-Year Change

+41.1%

OCUL Quarterly D&A Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Sector Rank

58.31%
OCUL quarterly depreciation & amortization is higher than 58.31% of companies in Healthcare sector

High & Low

All-time High

$959.00 K
OCUL quarterly depreciation & amortization is currently -0.83% below its historical high of $959.00 thousand

3-Year Low

$483.00 K
OCUL quarterly depreciation & amortization is currently +96.89% above its 3-year low

Earnings dates

Last Quarterly Earnings Report Date

Dec 31, 2024
OCUL previous earnings announcement was published on Dec 31, 2024

Next Quarterly Earnings Report Date

May 7, 2025
OCUL next earnings announcement is scheduled for May 7, 2025

Related metrics

Quarterly Total Expenses

$67.66 M
OCUL quarterly total expenses is $67.66 million

Quarterly Operating Expenses

$66.43 M
OCUL quarterly total operating expenses is $66.43 million

Quarterly Cost Of Goods Sold

$1.23 M
OCUL quarterly cost of goods sold is $1.23 million

Quarterly Interest Expense

$3.11 M
OCUL quarterly interest expense is $3.11 million

TTM D&A

$3.79 M
-$7000.00-0.18%

December 31, 2024

Summary

Performance

3-Month Change

-0.18%

1-Year Change

-0.18%

3-Year Change

+56.38%

5-Year Change

+49.64%

OCUL TTM D&A Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Sector Rank

57.56%
OCUL TTM depreciation & amortization is higher than 57.56% of companies in Healthcare sector

High & Low

All-time High

$3.79 M
OCUL TTM depreciation & amortization is currently -0.18% below its historical high of $3.79 million

3-Year Low

$2.04 M
OCUL TTM depreciation & amortization is currently +86.04% above its 3-year low

Earnings dates

Last Quarterly Earnings Report Date

Dec 31, 2024
OCUL previous earnings announcement was published on Dec 31, 2024

Next Quarterly Earnings Report Date

May 7, 2025
OCUL next earnings announcement is scheduled for May 7, 2025

Related metrics

Annual Total Expenses

$235.50 M
OCUL annual total expenses is $235.50 million

Annual Operating Expenses

$229.88 M
OCUL annual total operating expenses is $229.88 million

TTM Cost Of Goods Sold

$5.63 M
OCUL TTM cost of goods sold is $5.63 million

TTM Interest Expense

$13.58 M
OCUL TTM interest expense is $13.58 million

OCUL Depreciation And Amortization Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1 y1 year+26.9%-0.8%-0.2%
3 y3 years+56.4%+66.8%+56.4%
5 y5 years+49.6%+41.1%+49.6%

OCUL Depreciation And Amortization Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs lowTTM vs highTTM vs highTTM vs lowTTM vs low
3 y3-yearat high+79.5%-0.8%+96.9%-0.2%+86.0%
5 y5-yearat high+79.5%-0.8%+96.9%-0.2%+86.0%
alltimeall timeat high+837.1%-0.8%+933.7%-0.2%+3971.0%

Ocular Therapeutix Depreciation And Amortization History

DateAnnualQuarterlyTTM
Dec 2024
$3.79 M(+26.9%)
$951.00 K(-0.8%)
$3.79 M(-0.2%)
Sep 2024
-
$959.00 K(+0.3%)
$3.79 M(+1.9%)
Jun 2024
-
$956.00 K(+3.9%)
$3.72 M(+8.9%)
Mar 2024
-
$920.00 K(-4.0%)
$3.42 M(+14.6%)
Dec 2023
$2.98 M(+41.4%)
$958.00 K(+7.6%)
$2.98 M(+18.6%)
Sep 2023
-
$890.00 K(+36.5%)
$2.52 M(+17.8%)
Jun 2023
-
$652.00 K(+35.0%)
$2.13 M(+4.9%)
Mar 2023
-
$483.00 K(-1.6%)
$2.04 M(-3.5%)
Dec 2022
$2.11 M(-12.9%)
$491.00 K(-3.5%)
$2.11 M(-3.6%)
Sep 2022
-
$509.00 K(-7.8%)
$2.19 M(-3.7%)
Jun 2022
-
$552.00 K(-0.9%)
$2.27 M(-2.5%)
Mar 2022
-
$557.00 K(-2.3%)
$2.33 M(-3.7%)
Dec 2021
$2.42 M(-12.7%)
$570.00 K(-4.0%)
$2.42 M(-3.9%)
Sep 2021
-
$594.00 K(-2.8%)
$2.52 M(-2.7%)
Jun 2021
-
$611.00 K(-5.4%)
$2.59 M(-3.6%)
Mar 2021
-
$646.00 K(-3.1%)
$2.69 M(-3.2%)
Dec 2020
$2.77 M(+9.6%)
$667.00 K(+0.3%)
$2.77 M(-0.3%)
Sep 2020
-
$665.00 K(-5.9%)
$2.78 M(+13.3%)
Jun 2020
-
$707.00 K(-3.7%)
$2.45 M(-1.4%)
Mar 2020
-
$734.00 K(+8.9%)
$2.49 M(-1.7%)
Dec 2019
$2.53 M(+10.7%)
$674.00 K(+98.8%)
$2.53 M(+3.8%)
Sep 2019
-
$339.00 K(-54.3%)
$2.44 M(-8.8%)
Jun 2019
-
$741.00 K(-4.5%)
$2.67 M(+7.0%)
Mar 2019
-
$776.00 K(+33.3%)
$2.50 M(+9.2%)
DateAnnualQuarterlyTTM
Dec 2018
$2.29 M(+40.7%)
$582.00 K(+1.6%)
$2.29 M(+2.4%)
Sep 2018
-
$573.00 K(+1.2%)
$2.23 M(+4.3%)
Jun 2018
-
$566.00 K(+0.2%)
$2.14 M(+11.0%)
Mar 2018
-
$565.00 K(+7.0%)
$1.93 M(+18.7%)
Dec 2017
$1.63 M(+84.4%)
$528.00 K(+9.5%)
$1.63 M(+20.4%)
Sep 2017
-
$482.00 K(+36.2%)
$1.35 M(+24.5%)
Jun 2017
-
$354.00 K(+35.6%)
$1.08 M(+15.7%)
Mar 2017
-
$261.00 K(+3.2%)
$937.00 K(+6.4%)
Dec 2016
$881.00 K(+16.8%)
$253.00 K(+17.1%)
$881.00 K(+6.4%)
Sep 2016
-
$216.00 K(+4.3%)
$828.00 K(+2.7%)
Jun 2016
-
$207.00 K(+1.0%)
$806.00 K(+2.5%)
Mar 2016
-
$205.00 K(+2.5%)
$786.00 K(+4.2%)
Dec 2015
$754.00 K(+37.8%)
$200.00 K(+3.1%)
$754.00 K(+5.0%)
Sep 2015
-
$194.00 K(+3.7%)
$718.00 K(+8.3%)
Jun 2015
-
$187.00 K(+8.1%)
$663.00 K(+5.7%)
Mar 2015
-
$173.00 K(+5.5%)
$627.00 K(+14.6%)
Dec 2014
$547.00 K(+35.4%)
$164.00 K(+18.0%)
$547.00 K(+7.7%)
Sep 2014
-
$139.00 K(-7.9%)
$508.00 K(+10.2%)
Jun 2014
-
$151.00 K(+62.4%)
$461.00 K(+14.1%)
Mar 2014
-
$93.00 K(-25.6%)
$404.00 K(0.0%)
Dec 2013
$404.00 K(0.0%)
$125.00 K(+35.9%)
$404.00 K(+44.8%)
Sep 2013
-
$92.00 K(-2.1%)
$279.00 K(+49.2%)
Jun 2013
-
$94.00 K(+1.1%)
$187.00 K(+101.1%)
Mar 2013
-
$93.00 K
$93.00 K
Dec 2012
$404.00 K
-
-

FAQ

  • What is Ocular Therapeutix annual depreciation & amortization?
  • What is the all time high annual D&A for Ocular Therapeutix?
  • What is Ocular Therapeutix annual D&A year-on-year change?
  • What is Ocular Therapeutix quarterly depreciation & amortization?
  • What is the all time high quarterly D&A for Ocular Therapeutix?
  • What is Ocular Therapeutix quarterly D&A year-on-year change?
  • What is Ocular Therapeutix TTM depreciation & amortization?
  • What is the all time high TTM D&A for Ocular Therapeutix?
  • What is Ocular Therapeutix TTM D&A year-on-year change?

What is Ocular Therapeutix annual depreciation & amortization?

The current annual D&A of OCUL is $3.79 M

What is the all time high annual D&A for Ocular Therapeutix?

Ocular Therapeutix all-time high annual depreciation & amortization is $3.79 M

What is Ocular Therapeutix annual D&A year-on-year change?

Over the past year, OCUL annual depreciation & amortization has changed by +$803.00 K (+26.92%)

What is Ocular Therapeutix quarterly depreciation & amortization?

The current quarterly D&A of OCUL is $951.00 K

What is the all time high quarterly D&A for Ocular Therapeutix?

Ocular Therapeutix all-time high quarterly depreciation & amortization is $959.00 K

What is Ocular Therapeutix quarterly D&A year-on-year change?

Over the past year, OCUL quarterly depreciation & amortization has changed by -$8000.00 (-0.83%)

What is Ocular Therapeutix TTM depreciation & amortization?

The current TTM D&A of OCUL is $3.79 M

What is the all time high TTM D&A for Ocular Therapeutix?

Ocular Therapeutix all-time high TTM depreciation & amortization is $3.79 M

What is Ocular Therapeutix TTM D&A year-on-year change?

Over the past year, OCUL TTM depreciation & amortization has changed by -$7000.00 (-0.18%)